4NEURON

At 4NEURON, we are driven by a singular, noble mission: to revolutionize the lives of the 50 million epilepsy patients worldwide. Our innovative approach encompasses both human and companion animal care, offering groundbreaking and safe treatment solutions.

We have meticulously designed and developed a pioneering class of compounds that set new standards in epilepsy treatment. Our flagship small molecule, the result of years of dedication and scientific rigor, has unveiled a groundbreaking breakthrough. In acute viable brain slices from multi drug-resistant human epilepsy patients, it has demonstrated exceptional anti-seizure efficacy and an extraordinary reduction in side effects compared to existing therapies.

With our orally available, non-toxic, non-phototoxic, and non-neurotoxic drug candidates, we have positioned ourselves as the vanguard of innovation in the healthcare industry. We are delivering life-changing solutions for patients.